News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ELVAF market cap is 7.95M. The company's latest EPS is CHF -5.9975 and P/E is -0.18.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 8.93M | 11.6M | 7.54M | 9.88M | 15.54M |
| Operating Income | -30.7M | -20.13M | -24.91M | -42.03M | -40.39M |
| Net Income | -29.21M | -21.64M | -29.87M | -41.27M | -43.37M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 213.02M | 192.08M | 166.89M | 156.17M | 131.01M |
| Total Liabilities | 18.86M | 19.52M | 21.8M | 24.4M | 24.77M |
| Total Equity | 194.16M | 172.56M | 145.09M | 131.77M | 106.24M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -23.61M | -14.16M | -23.36M | -29.79M | -18.88M |
| Investing | -12.17M | -5.33M | -5.6M | -4.64M | -1.76M |
| Financing | -1M | -920k | 8.86M | 25.72M | 14.77M |
| Market Cap | 7.95M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 0.51 |
| Price to Cash Ratio | 1.55 |
| Price to Book Ratio | 0.07 |
| Dividend Yield | - |
| Shares Outstanding | 7.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 171 |
| 52 Week Change | -83.56% |
| 52 Week High | 6.70 |
| 52 Week Low | 0.8221 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Evolva Holding SA (CE) |
| Address |
duggingerstra��e 23 reinach 4153 |
| Website | https://www.evolva.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
